Matthew Plavan
2018 - Arcadia Biosciences
In 2018, Matthew Plavan earned a total compensation of $583K as President, Arcadia Specialty Genomics and Chief Financial Officer at Arcadia Biosciences, a 20% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $123,000 |
|---|---|
| Option Awards | $170,392 |
| Salary | $289,618 |
| Total | $583,010 |
Plavan received $289.6K in salary, accounting for 50% of the total pay in 2018.
Plavan also received $123K in non-equity incentive plan and $170.4K in option awards.
Rankings
In 2018, Matthew Plavan's compensation ranked 11,380th out of 14,244 executives tracked by ExecPay. In other words, Plavan earned more than 20.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,380 out of 14,244 | 20th |
Division Agriculture, Forestry, And Fishing | 33 out of 44 | 25th |
Major group Agricultural Production Crops | 19 out of 26 | 27th |
Source: SEC filing on April 18, 2019.
Plavan's colleagues
We found three more compensation records of executives who worked with Matthew Plavan at Arcadia Biosciences in 2018.
News
Arcadia Biosciences CEO Matthew Plavan's 2021 pay jumps 102% to $1.6M
April 19, 2022
Arcadia Biosciences CEO Matthew Plavan's 2020 pay jumps 37% to $794K
April 20, 2021
Arcadia Biosciences CEO Matthew Plavan's 2019 pay stays at $581K
April 17, 2020
Arcadia Biosciences CEO Rajendra Ketkar's 2018 pay jumps 40% to $904K
April 18, 2019